Literature DB >> 14746812

The Class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions.

Jerome A Langer1, E Cali Cutrone, Sergei Kotenko.   

Abstract

Expanded genomic information has driven the discovery of new members of the human Class II family of cytokine receptors (CRF2), which now includes 12 proteins. The corresponding cytokines have been identified, paired with their receptors and initially characterized for function. These cytokines include: a new human Type I IFN, IFN-kappa; molecules related to IL-10 (IL-19, IL-20, IL-22, IL-24, IL-26); and IFN-lambdas (IL-28/29), which have antiviral and cell stimulatory activities reminiscent of Type I IFNs, but act through a distinct receptor. In response to ligand binding, the CRF2 proteins form heterodimers, leading to cytokine-specific cellular responses; these diverse physiological functions are just beginning to be explored. Progress in structural and mutational analysis of ligand-receptor interactions now presents a more reliable framework for understanding receptor-ligand interactions, and for predicting key regions in less well studied members of the CRF2 family. The relationships between the CRF2 proteins will be summarized, as will the progress in identifying patterns of receptor interactions with ligands.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14746812     DOI: 10.1016/j.cytogfr.2003.10.001

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  51 in total

1.  The EM structure of a type I interferon-receptor complex reveals a novel mechanism for cytokine signaling.

Authors:  Zongli Li; Jennifer Julia Strunk; Peter Lamken; Jacob Piehler; Thomas Walz
Journal:  J Mol Biol       Date:  2007-12-08       Impact factor: 5.469

2.  Combined promoter haplotypes of the IL10R genes are associated with protection against severe malaria in Gabonese children.

Authors:  T P Velavan; Birgül Büyükyazici; Peter G Kremsner; Jürgen F J Kun
Journal:  Immunogenetics       Date:  2011-08-04       Impact factor: 2.846

3.  Standardization of human IL-29 (IFN-λ1): establishment of a World Health Organization international reference reagent for IL-29 (IFN-λ1).

Authors:  Anthony Meager; Alan Heath; Paula Dilger; Kathryn Zoon; Meenu Wadhwa
Journal:  J Interferon Cytokine Res       Date:  2014-06-23       Impact factor: 2.607

Review 4.  Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention.

Authors:  Ning Zhang; Hai-Feng Pan; Dong-Qing Ye
Journal:  Mol Cell Biochem       Date:  2011-03-08       Impact factor: 3.396

Review 5.  Contribution of type III interferons to antiviral immunity: location, location, location.

Authors:  Sergei V Kotenko; Joan E Durbin
Journal:  J Biol Chem       Date:  2017-03-13       Impact factor: 5.157

6.  Interferon-alpha and -beta differentially regulate osteoclastogenesis: role of differential induction of chemokine CXCL11 expression.

Authors:  Luiz F Leomil Coelho; Gabriel Magno de Freitas Almeida; Franck J D Mennechet; Anne Blangy; Gilles Uzé
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-04       Impact factor: 11.205

7.  Crystal structure of the interferon gamma receptor alpha chain from chicken reveals an undetected extra helix compared with the human counterparts.

Authors:  Zhiguang Ping; Jianxun Qi; Yanling Sun; Guangwen Lu; Yi Shi; Xiaojia Wang; George F Gao; Ming Wang
Journal:  J Interferon Cytokine Res       Date:  2013-11-27       Impact factor: 2.607

Review 8.  Organogenesis and tumorigenesis: insight from the JAK/STAT pathway in the Drosophila eye.

Authors:  Ying-Hsuan Wang; Min-Lang Huang
Journal:  Dev Dyn       Date:  2010-10       Impact factor: 3.780

Review 9.  Subversion of cytokine networks by virally encoded decoy receptors.

Authors:  Megan L Epperson; Chung A Lee; Daved H Fremont
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

10.  Interleukin-22 forms dimers that are recognized by two interleukin-22R1 receptor chains.

Authors:  Mario de Oliveira Neto; José Ribamar Ferreira; Didier Colau; Hannes Fischer; Alessandro S Nascimento; Aldo F Craievich; Laure Dumoutier; Jean-Christophe Renauld; Igor Polikarpov
Journal:  Biophys J       Date:  2007-11-16       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.